Table 1.
Demographic and clinical characteristics of the patients (n = 59)
| Clinical feature | No. (%) |
|---|---|
|
| |
| Median age (range) | 60 years (26–86 years) |
| Sex | |
| Male | 43 (73) |
| Female | 16 (27) |
| BMI (range) | 29.4 (19.1–48.3) |
| Location of tumor | |
| Siewert type III | 29(49) |
| Distal stomach | 30 (51) |
| Tumor differentiation | |
| Well differentiated | 0 (0) |
| Moderately differentiated | 18 (31) |
| Poorly differentiated | 41 (69) |
| Lauren classification | |
| Intestinal | 21 (36) |
| Diffuse | 38(64) |
| Signet ring cells | |
| Yes | 26 (44) |
| No | 33 (56) |
| Induction chemotherapy | |
| Yes | 52(88) |
| No | 7 (12) |
| Baseline T category | |
| T1 | 0 (0) |
| T2 | 5 (8) |
| T3 | 52 (88) |
| T4 | 2 (3) |
| Baseline N category | |
| NO | 25(42) |
| N1 | 15(25) |
| N2 | 11 (19) |
| N3 | 8 (14) |
| Baseline clinical stage | |
| I | 4 (7) |
| IIA | 1 (2) |
| IIB | 19 (32) |
| III | 31 (52) |
| IV | 4 (7) |
| Response | |
| P0 | 10 (17) |
| P1 | 35 (59) |
| P2 | 14 (24) |
| Primary SUVmax (range) | 7.3 (0–28.2) |
| Primary volume (range) | 15.2 (0–168.5) |
| Primary TLG (range) | 56.6 (0–1881.5) |